TPC

Takeda Pharmaceutical Company Portfolio holdings

AUM $19.6M
1-Year Est. Return 13.61%
This Quarter Est. Return
1 Year Est. Return
-13.61%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$16.2M
AUM Growth
-$10.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
11
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HLVX
1
DELISTED
HilleVax
HLVX
$9.75M 60.21%
6,724,000
OVID icon
2
Ovid Therapeutics
OVID
$98.1M
$2.35M 14.51%
7,531,996
XLO icon
3
Xilio Therapeutics
XLO
$44M
$1.07M 6.6%
1,475,121
EQ icon
4
Equillium
EQ
$92.2M
$712K 4.4%
1,824,977
AMWL icon
5
American Well
AMWL
$82.2M
$613K 3.78%
77,733
STTK icon
6
Shattuck Labs
STTK
$95.3M
$490K 3.02%
515,619
LYEL icon
7
Lyell Immunopharma
LYEL
$318M
$443K 2.74%
41,166
TSBX
8
DELISTED
Turnstone Biologics
TSBX
$367K 2.27%
895,824
RANI icon
9
Rani Therapeutics
RANI
$210M
$256K 1.58%
203,190
THRD
10
DELISTED
Third Harmonic Bio
THRD
$128K 0.79%
36,835
LAB icon
11
Standard BioTools
LAB
$474M
$17.8K 0.11%
16,515